Nanomedical Diagnostics is using a patent-pending nanoscale, graphene based biosensor to improve the speed, cost, and accuracy of clincial diagnosis and protein research. Previously known only in the most advanced academic physics labs, this product represents the first commercial application of graphene. The technology directly binds our body's biology to an electronic sensor chip, enabling computerized data about our personal biochemistry.